A two-drug combination for treating advanced kidney cancer has shown sustained and durable clinical benefit in more than five ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

EXEL rides on strong Cabometyx demand in RCC and NET, but Q2 sales miss and rising competition cloud the outlook.

During a live event, Sumanta K. Pal, MD, discussed lenvatinib dosing and tivozanib efficacy for patients with metastatic ...

Kidney cancer risks, symptoms, treatment, and prevention, including the benefits of robotic-assisted surgery for optimal ...

James Whale, a longtime radio and television host from Britain, has died at age 74. His death was announced on August 4, 2025 ...

Bradley A. McGregor, MD, director of Clinical Research for the Lank Center of Genitourinary Oncology at the Dana-Farber Cancer Institute, discusses the advancements in treating metastatic renal cell ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a ...

The beloved radio presenter was first diagnosed in 2000, and doctors predicted he had three months to live before he ...